Pharmaceuticals & Biotechnology • Mid Cap

Glaxosmithkline Pharmaceuticals Ltd.

₹2,524.80▲ 24.60 (0.98%)

Data is being fetched with a 2 min delay

Prev. Close₹2,500.20▲ 0.98%

Open₹2,502.00▲ 0.91%

Performance

LowHigh

2,489.302,544.80

52W Low52W High

2,088.103,120.70

Turnover₹29.64 Cr

Volume Traded1.17L

P/E Ratio48.80

Market Cap₹46402.01 Cr

Avg. Volume71.17K

Stories & Reports

Bajaj Auto, Bank Of India, Glaxo, ICICI Lombard, Torrent Pharma, Uno Minda Dividend Record Date: Last Day To Buy Shares To Qualify

Corporate Actions This Week: TCS, Bajaj Auto, ITC, Glaxo, Bank of India, UNO Minda And More In Focus

Unilever to Weigh Raising Offer for Glaxo Consumer Unit

Glaxo Rejects $68 Billion Unilever Bid for Consumer Business

Glaxo Board and Activist Hedge Fund Bluebell Spar in New Letters

Activist Hedge Fund Bluebell Wants Glaxo Chairman Replaced

V/S

Glaxosmithkline Pharmaceuticals Ltd.+24.60 (0.98%)NIFTY 50+493.75 (2.01%)

Announcements

GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Link of Recording

View Full Doc

Glaxosmithkline Pharmaceuticals Ltd. Share Price

As of 7 November 2026, Glaxosmithkline Pharmaceuticals Ltd. share price is ₹2,524.80. The stock opened at ₹2,502.00, compared to its previous close of ₹2,500.20. During today's trading session, Glaxosmithkline Pharmaceuticals Ltd. share price moved in the range of ₹2,489.30 to ₹2,544.80.

Looking at its last 52-week performance, the stock has touched a low of ₹2,088.10 and a high of ₹3,120.70. On the performance front, Glaxosmithkline Pharmaceuticals Ltd. share price is down 3.10% on a year-on-year basis.

The market capitalization of Glaxosmithkline Pharmaceuticals Ltd. is ₹46402.01 Cr, with a P/E ratio of 48.80.